TMO vs ULS · P/E 24, rev $44.56B vs P/E 55, rev $2.87B
Thermo Fisher Scientific Inc (TMO) versus UL Solutions Inc. (ULS) — a side-by-side from cached financials, not a winner call.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
UL Solutions Inc. (ULS) is a specialty business services company listed on NYSE.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Latest reported ULS revenue for 2024-12-31 was $2.87B. Net income was $345.0M. Revenue was up 7.2% from 2023-12-31 to 2024-12-31. ULS currently screens at market cap $18.97B and trailing P/E 54.7.
TMO currently screens at market cap $153.06B and trailing P/E 23.8. ULS currently screens at market cap $18.97B and trailing P/E 54.7.
Not investment advice. Open the TMO and ULS stock pages for the full models.
Not investment advice.